These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23082777)

  • 1. Long-term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia.
    Thomas NJ; Brooke AM; Besser GM
    Clin Endocrinol (Oxf); 2013 May; 78(5):799-800. PubMed ID: 23082777
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic control in patients with insulinoma treated with everolimus.
    Kulke MH; Bergsland EK; Yao JC
    N Engl J Med; 2009 Jan; 360(2):195-7. PubMed ID: 19129539
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
    Ong GS; Henley DE; Hurley D; Turner JH; Claringbold PG; Fegan PG
    Eur J Endocrinol; 2010 May; 162(5):1001-8. PubMed ID: 20164213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
    Bernard V; Lombard-Bohas C; Taquet MC; Caroli-Bosc FX; Ruszniewski P; Niccoli P; Guimbaud R; Chougnet CN; Goichot B; Rohmer V; Borson-Chazot F; Baudin E;
    Eur J Endocrinol; 2013 May; 168(5):665-74. PubMed ID: 23392213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
    Asayama M; Yamada-Murano T; Hara H; Ooki A; Kurosumi M; Yamaguchi K
    Jpn J Clin Oncol; 2014 Feb; 44(2):186-90. PubMed ID: 24367043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
    Fiebrich HB; Siemerink EJ; Brouwers AH; Links TP; Remkes WS; Hospers GA; de Vries EG
    Oncologist; 2011; 16(6):783-7. PubMed ID: 21482586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocardia brain abscess in a patient treated with everolimus for a metastatic insulinoma.
    Walter T; Zadeh G; Hawryluk G; Krzyzanowska MK
    J Clin Oncol; 2013 Feb; 31(6):e73-5. PubMed ID: 23182991
    [No Abstract]   [Full Text] [Related]  

  • 8. Everolimus resolving hypoglycemia, producing hyperglycemia, and necessitating insulin use in a patient with diabetes and nonresectable malignant insulinoma.
    Ferrer-García JC; Tolosa-Torréns M; Hernando-Meliá C; Arribas-Palomar L; Sánchez-Juan C
    Endocr Pract; 2011; 17(2):e17-20. PubMed ID: 21247848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment: symptomatic treatment of hypoglycaemia.
    Tabarin A; Goichot B;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):196-9. PubMed ID: 23791453
    [No Abstract]   [Full Text] [Related]  

  • 10. The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring.
    Yanagiya S; Cho KY; Nakamura A; Nomoto H; Kawamoto Y; Kawakubo K; Komatsu Y; Mitsuhashi T; Miyoshi H; Atsumi T
    Intern Med; 2018 Sep; 57(17):2527-2531. PubMed ID: 29877259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
    Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M
    Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma.
    Hendren NS; Panach K; Brown TJ; Peng L; Beg MS; Weissler J; Mirfakhraee S
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):341-343. PubMed ID: 29055143
    [No Abstract]   [Full Text] [Related]  

  • 14. Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan.
    Wade AN; Cheng G; Teitelbaum U; Patel AA; Alavi A; Rickels MR
    Pancreas; 2011 Jan; 40(1):173-5. PubMed ID: 21160385
    [No Abstract]   [Full Text] [Related]  

  • 15. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.
    Vezzosi D; Bennet A; Courbon F; Caron P
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):904-11. PubMed ID: 18031316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
    Hoff AO; Vassilopoulou-Sellin R
    Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2-induced hypoglycemia unresponsive to everolimus.
    Korevaar TI; Ragazzoni F; Weaver A; Karavitaki N; Grossman AB
    QJM; 2014 Apr; 107(4):297-300. PubMed ID: 22171014
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous glucose monitoring in patients with insulinoma.
    Munir A; Choudhary P; Harrison B; Heller S; Newell-Price J
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):912-8. PubMed ID: 18088393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma: how reliable is the biochemical evidence?
    Chammas NK; Teale JD; Quin JD
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):689-93. PubMed ID: 14629810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mysterious case of normalising blood sugar: insulinoma in a long-standing diabetic patient.
    Hameed MF; Hoyle GE; Muir Z
    Age Ageing; 2006 May; 35(3):317-8. PubMed ID: 16638774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.